Stay updated with breaking news from Seth Lederman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tonix Pharmaceuticals Holding Corp. (TNXP), Tuesday announced that it is planning for regulatory filings in Japan, China and the U.S., following the positive results from its clinical pharmacokinetic bridging study of Tonmya.
27.02.2024 - Tonix plans to File a Clinical Trial Notification (CTN) in Japan and Investigational New Drug (IND) application in China to support a registration-enabling Asian Phase 3 study without dosage adjustment based on U.S. registrational Phase 3 data ... Seite 1
Tonix Pharmaceuticals Holding Corp. (TNXP), Tuesday announced that it is planning for regulatory filings in Japan, China and the U.S., following the positive results from its clinical pharmacokinetic bridging study of Tonmya.
New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series...
New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT...